This article is more than 5 years old. Information may no longer be current.
Fox Chase appoints chair of hematology/oncology department
Click Here to Manage Email Alerts
Martin J. Edelman, MD, has been appointed chair of the department of hematology/oncology at Fox Chase Cancer Center.
Edelman, recognized for his expertise in the treatment of and research into lung cancer, also will serve as deputy cancer center director for clinical research. His appointment will take effect Feb. 6.
His research interests include approaches that integrate surgery, radiation and chemotherapy in the management of lung cancer.
“Dr. Edelman is a visionary in his field, and I am confident he will lead our department of hematology/oncology to even greater heights,” Richard I. Fisher, MD, president and CEO of Fox Chase, said in a press release. “I am delighted that he has chosen to become a key part of our faculty, and I look forward to what we will all achieve together in the coming years.”
Edelman will join Fox Chase from University of Maryland Greenebaum Comprehensive Cancer Center, where he served as head of the section of solid tumor oncology and associate director of the division of hematology/oncology. He also served as professor of medicine and radiation oncology at University of Maryland School of Medicine.
“Fox Chase Cancer Center has a national and international reputation for excellence,” Edelman said in the press release. “I look forward to working with leading experts in cancer research and treatment as we continue the institution’s long legacy of progress against cancer.”